Produces natural ingredients such as biotin via precision fermentation
| Date | Round | Amount |
|---|---|---|
| Jul 2022 | Series B Copenhagen biotech Biosyntia raised a EUR11.5M Series B from the European Circular Bioeconomy Fund, Sofinnova Partners and Novo Seeds. | $12.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.